Skip to main content

Search Tufts Medicine

Displaying 221 - 225 of 225
clinical trial
...

This is an observational study to assess the the burden of neuropathic involvement in wild-type transthyretin amyloidosis

clinical trial
...

This phase III trial compares the effects of nivolumab with chemo-immunotherapy versus chemo-immunotherapy alone in treating patients with newly diagnosed primary mediastinal B-cell lymphoma (PMBCL). 

clinical trial
...

The primary objective is to evaluate the efficacy of levosimendan TNX-103 compared with placebo in subjects with PH-HFpEF as measured by the change in 6-Minute Walk Distance from Day 1 to Week 12. This is a multicenter, parallel, double-blind study in subjects with PH-HFpEF and will be screened for a 1:1 ratio to receive an oral dose of 2 mg/day levosimendan or placebo for Weeks 1 to 4 and 3 mg/day for Weeks 5 to 12.

department
As one of the first departments of its kind established in Boston, the Radiation Oncology Department has earned a reputation for innovation in patient care, research and training. We harness the power of radiation therapy to treat cancers and specific benign conditions like keloids, trigeminal neuralgia and inflammatory diseases.
department
Since the late 19th century, the Department of Pediatrics has been improving and redefining pediatric care, research and training.
Jump back to top